VivekYReddyMD

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Professor, Medicine, Icahn School of Medicine

Overview of Dr. Reddy

Dr. Vivek Reddy is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital and NYC Health + Hospitals / Bellevue. He received his medical degree from University of Michigan Medical School and has been in practice 22 years. Dr. Reddy accepts several types of health insurance, listed below. He is one of 616 doctors at The Mount Sinai Hospital and one of 133 doctors at NYC Health + Hospitals / Bellevue who specialize in Cardiology. He has more than 100 publications and over 500 citings.

Office
5 E 98th St
3RD floor
New York, NY 10029
Book by Phone+1(361) 426-7055

Fax+1 212-876-1493

Education & Training

Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 1999 - 2001
University of ChicagoFellowship, Cardiovascular Disease, 1997 - 1999
Yale-New Haven Medical CenterResidency, Internal Medicine, 1995 - 1997
University of Michigan Medical SchoolClass of 1995

Certifications & Licensure

CA State Medical License 2006 - Present
FL State Medical License 2008 - Present
NY State Medical License 2009 - 2025
CT State Medical License 2020 - 2023
NJ State Medical License 2022 - 2023
MA State Medical License 1999 - 2010
IL State Medical License 1997 - 2000

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014
New York Magazine: Top Doctors Castle Connolly, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs Start of enrollment: 2007 Mar 01
Terminated
Phase 3
Effect of Balloon Cryoablation on Left Atrial Function Start of enrollment: 2010 Jun 01
Completed
Not Applicable
ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Start of enrollment: 2009 Oct 01
Completed
Not Applicable
Post-Market Randomized Trial: Endoscopically- Guided Ablation vs. Radiofrequency Ablation Start of enrollment: 2009 Dec 01
Terminated
Phase 4
Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy Start of enrollment: 2010 Nov 01
Completed
Phase 3
Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping Start of enrollment: 2010 Oct 01
Unknown status
Phase 1, Phase 2
TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Start of enrollment: 2011 Jan 01
Completed
Not Applicable
Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation Start of enrollment: 2010 Sep 01
Completed
Not Applicable
INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Terminated
Phase 3
HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF) Start of enrollment: 2012 Jan 01
Completed
Phase 3
Deviating the Esophagus in Atrial Fibrillation Ablation Start of enrollment: 2011 Nov 01
Terminated
Not Applicable
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia Start of enrollment: 2011 Sep 01
Terminated
Not Applicable
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators Start of enrollment: 2012 Jun 01
Terminated
Phase 4
The Effect of Blended Sensor Efficiency on Relieving the Heart's Inability to Increase Its Rate During Exercise Start of enrollment: 2012 Mar 01
Terminated
Not Applicable
Renal Sympathetic Denervation for the Management of Chronic Hypertension Start of enrollment: 2011 Jan 01
Completed
Not Applicable
Impact of Renal SympAthetic DenerVation on Chronic HypErtension Start of enrollment: 2011 Oct 01
Terminated
Not Applicable
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation Start of enrollment: 2012 Sep 17
Completed
Not Applicable
Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2012 Aug 01
Completed
Phase 4
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2012 Oct 01
Completed
Not Applicable
REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients Start of enrollment: 2015 Oct 22
Completed
Not Applicable
REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2013 Nov 22
Completed
Not Applicable
Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation? Start of enrollment: 2014 May 01
Completed
Join now to see all

Publications & Presentations

PubMed

329 citations
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Pavel Osmancik, Dalibor Herman, Petr Neuzil, Pavel Hala, Milos Taborsky
Journal of the American College of Cardiology. 2020-06-30
2 citations
Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fraction.
Libor Dujka, Petr Neužil, Vivek Reddy, Martin Mates, Tomáš Mráz
The Journal of International Medical Research. 2022-05-01
201 citations
Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial.
Saibal Kar, Shephal K. Doshi, Ashish Sadhu, Rodney Horton, Jose Osorio
Circulation. 2021-05-04

Authored Content

Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve ProlapseMay 2020
Device-Related Thrombus: Understanding and Managing the ""Achilles Heel"" of LAA ClosureSeptember 2018
Device-Related Thrombus: Understanding and Managing the "Achilles Heel" of LAA ClosureSeptember 2018
Device-Related Thrombus: Understanding and Managing the "Achilles Heel" of LAA ClosureSeptember 2018
Join now to see all

Press Mentions

Medtronic Bags USFDA Approval of Affera Mapping and Ablation System and Sphere-9 CatheterOctober 29th, 2024
Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal TrialSeptember 30th, 2024
Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation PatientsJuly 8th, 2024
Join now to see all

Grant Support

Visualizing The Substrate For Sudden Cardiac DeathNational Institute Of Biomedical Imaging And Bioengineering2005–2006
Substrate Mapping &Ablation Of Ventricular TachycardiaNational Heart, Lung, And Blood Institute2002–2006

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment